These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 24992072

  • 1. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
    Yoon YK, Ali MA, Wei AC, Shirazi AN, Parang K, Choon TS.
    Eur J Med Chem; 2014 Aug 18; 83():448-54. PubMed ID: 24992072
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
    Yoon YK, Ali MA, Wei AC, Choon TS, Osman H, Parang K, Shirazi AN.
    Bioorg Med Chem; 2014 Jan 15; 22(2):703-10. PubMed ID: 24387981
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
    Wang YT, Qin YJ, Yang N, Zhang YL, Liu CH, Zhu HL.
    Eur J Med Chem; 2015 Jun 24; 99():125-37. PubMed ID: 26070164
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
    Sakai T, Matsumoto Y, Ishikawa M, Sugita K, Hashimoto Y, Wakai N, Kitao A, Morishita E, Toyoshima C, Hayashi T, Akiyama T.
    Bioorg Med Chem; 2015 Jan 15; 23(2):328-39. PubMed ID: 25515955
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
    El-Nassan HB.
    Eur J Med Chem; 2012 Jul 15; 53():22-7. PubMed ID: 22542105
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
    Romero-Parra J, Mella-Raipán J, Palmieri V, Allarà M, Torres MJ, Pessoa-Mahana H, Iturriaga-Vásquez P, Escobar R, Faúndez M, Di Marzo V, Pessoa-Mahana CD.
    Eur J Med Chem; 2016 Nov 29; 124():17-35. PubMed ID: 27560280
    [Abstract] [Full Text] [Related]

  • 9. Purine-benzimidazole hybrids: synthesis, single crystal determination and in vitro evaluation of antitumor activities.
    Sharma A, Luxami V, Paul K.
    Eur J Med Chem; 2015 Mar 26; 93():414-22. PubMed ID: 25728022
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis and biological evaluation of 4-anilinothieno[2,3-d]pyrimidine-based hydroxamic acid derivatives as novel histone deacetylase inhibitors.
    Yang W, Li L, Ji X, Wu X, Su M, Sheng L, Zang Y, Li J, Liu H.
    Bioorg Med Chem; 2014 Nov 01; 22(21):6146-55. PubMed ID: 25261927
    [Abstract] [Full Text] [Related]

  • 11. Structural Modifications of Benzimidazoles via Multi-Step Synthesis and Their Impact on Sirtuin-Inhibitory Activity.
    Yoon YK, Choon TS.
    Arch Pharm (Weinheim); 2016 Jan 01; 349(1):1-8. PubMed ID: 26616218
    [Abstract] [Full Text] [Related]

  • 12. Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.
    Huang S, Song C, Wang X, Zhang G, Wang Y, Jiang X, Sun Q, Huang L, Xiang R, Hu Y, Li L, Yang S.
    J Chem Inf Model; 2017 Apr 24; 57(4):669-679. PubMed ID: 28301150
    [Abstract] [Full Text] [Related]

  • 13. Docking and binding free energy calculations of sirtuin inhibitors.
    Karaman B, Sippl W.
    Eur J Med Chem; 2015 Mar 26; 93():584-98. PubMed ID: 25748123
    [Abstract] [Full Text] [Related]

  • 14. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.
    Yagci S, Gozelle M, Kaya SG, Ozkan Y, Aksel AB, Bakar-Ates F, Dundar Y, Eren G.
    Bioorg Med Chem; 2021 Jan 15; 30():115961. PubMed ID: 33360574
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and docking studies on benzamide derivatives as histone deacetylase inhibitors.
    Lu A, Luo H, Shi M, Wu G, Yuan Y, Liu J, Tang F.
    Bioorg Med Chem Lett; 2011 Aug 15; 21(16):4924-7. PubMed ID: 21741834
    [Abstract] [Full Text] [Related]

  • 16. Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents.
    Wang T, Sepulveda M, Gonzales P, Gately S.
    Bioorg Med Chem Lett; 2013 Sep 01; 23(17):4790-3. PubMed ID: 23906422
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
    Luo Y, Xiao F, Qian S, Lu W, Yang B.
    Eur J Med Chem; 2011 Jan 01; 46(1):417-22. PubMed ID: 21115212
    [Abstract] [Full Text] [Related]

  • 18. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
    Shi L, Wu TT, Wang Z, Xue JY, Xu YG.
    Eur J Med Chem; 2014 Sep 12; 84():698-707. PubMed ID: 25064347
    [Abstract] [Full Text] [Related]

  • 19. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
    Rathore A, Rahman MU, Siddiqui AA, Ali A, Shaharyar M.
    Arch Pharm (Weinheim); 2014 Dec 12; 347(12):923-35. PubMed ID: 25303727
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors.
    Akhtar MJ, Siddiqui AA, Khan AA, Ali Z, Dewangan RP, Pasha S, Yar MS.
    Eur J Med Chem; 2017 Jan 27; 126():853-869. PubMed ID: 27987485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.